Evidence map›Paper›PMID 14990688›Full record

ArticleJournal of virology2004

Requirements for CEACAMs and cholesterol during murine coronavirus cell entry.

Edward B Thorp, Thomas M Gallagher

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Meta-analysis of Effect of Statins in Patients with COVID-19.The American journal of cardiology · 2020
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Membrane Rafts: Portals for Viral Entry.Frontiers in microbiology · 2021
    Review
  19. Article
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Edward B ThorpDepartment of Microbiology and Immunology, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Thomas M Gallagher
Loyola University Medical Center · US

Funding

Experimental Immunology Training GrantT32AI007508 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI KNIGHT, KATHERINE L. · 1997 to 2022
$4.0M
MOLECULAR DISSECTION OF THE CORONAVIRUS SPIKER01NS031616 · NINDS · LOYOLA UNIVERSITY CHICAGO · PI GALLAGHER, THOMAS MILLER · 1999 to 2002
$743k
MOLECULAR DISSECTION OF THE CORONAVIRUS SPIKER29NS031616 · NINDS · LOYOLA UNIVERSITY CHICAGO · PI GALLAGHER, THOMAS MILLER · 1994 to 1998
–
NIAID NIH HHS AI007508NIAID NIH HHS T32 AI007508NINDS NIH HHS NS-31616
6 · The paper itself

Abstract

Previous reports have documented that cholesterol supplementations increase cytopathic effects in tissue culture and also intensify in vivo pathogenicities during infection by the enveloped coronavirus murine hepatitis virus (MHV). To move toward a mechanistic understanding of these phenomena, we used growth media enriched with methyl-beta-cyclodextrin or cholesterol to reduce or elevate cellular membrane sterols, respectively. Cholesterol depletions reduced plaque development 2- to 20-fold, depending on the infecting MHV strain, while supplementations increased susceptibility 2- to 10-fold. These various cholesterol levels had no effect on the binding of viral spike (S) proteins to cellular carcinoembryonic antigen-related cell adhesion molecule (CEACAM) receptors, rather they correlated directly with S-protein-mediated membrane fusion activities. We considered whether cholesterol was indirectly involved in membrane fusion by condensing CEACAMs into "lipid raft" membrane microdomains, thereby creating opportunities for simultaneous binding of multiple S proteins that subsequently cooperate in the receptor-triggered membrane fusion process. However, the vast majority of CEACAMs were solubilized by cold Triton X-100 (TX-100), indicating their absence from lipid rafts. Furthermore, engineered CEACAMs appended to glycosylphosphatidylinositol anchors partitioned with TX-100-resistant lipid rafts, but cells bearing these raft-associated CEACAMs were not hypersensitive to MHV infection. These findings argued against the importance of cholesterol-dependent CEACAM localizations into membrane microdomains for MHV entry, instead suggesting that cholesterol had a more direct role. Indeed, we found that cholesterol was required even for those rare S-mediated fusions taking place in the absence of CEACAMs. We conclude that cholesterol is an essential membrane fusion cofactor that can act with or without CEACAMs to promote MHV entry.

Indexed as

Membrane FusionAmino Acid SequenceAnimalsAntigens, CDAntigens, DifferentiationCarcinoembryonic AntigenCell Adhesion MoleculesCell LineCholesterolCricetinaeHeLa CellsHumansMembrane MicrodomainsMiceMolecular Sequence DataMurine hepatitis virusAntigens, CDAntigens, DifferentiationCarcinoembryonic AntigenCD66 antigensCeacam1 protein, mouseCell Adhesion MoleculesCholesterolOctoxynol

Identifiers

PMID14990688
PMCPMC353758
OpenAlexW2093132593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.